Protagonist Therapeutics (PTGX) Stock Chart & Stock Price History $41.11 +0.07 (+0.17%) (As of 11/15/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Protagonist Therapeutics Stock Price Performance 5 Day Performance-4.77%1 Month Performance-12.57%3 Month Performance-0.70%6 Month Performance+33.73%Year-To-Date Performance+79.28%1 Year Performance+144.56% Receive PTGX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Protagonist Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address How one pattern has averaged an 85% return per year since the pandemic. (Ad)Over the last 5 years Roger Scott has done some pretty incredible things… He’s found hundreds of winning opportunities… He’s created some incredible strategies… And he’s even designed some amazing tools… But there is one thing he’s always kept close to the chest… And in this case, it’s been a very particular stock market pattern…. A pattern he calls the World's Most Predictable Pattern…Follow this link here and enter your email address to sign up… PTGX Stock Chart for Sunday, November, 17, 2024 PTGX Chart by TradingView Protagonist Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/15/2024$41.04$41.11+0.17%$41.84$39.411.09 million shs$2.45 billion11/14/2024$42.67$41.04-3.82%$43.14$40.91617,717 shs$2.45 billion11/13/2024$43.17$42.67-1.16%$43.85$42.39594,301 shs$2.54 billion11/12/2024$46.50$43.17-7.16%$46.64$42.95650,848 shs$2.54 billion11/11/2024$46.23$46.50+0.58%$48.35$46.44558,206 shs$2.74 billion11/08/2024$47.61$46.23-2.90%$48.86$45.27680,884 shs$2.72 billion Get the Latest News and Ratings for PTGX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protagonist Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/07/2024$47.60$47.61+0.02%$48.69$46.53427,853 shs$2.80 billion11/06/2024$45.90$47.60+3.70%$48.67$46.391.08 million shs$2.80 billion11/05/2024$46.76$45.90-1.84%$47.31$43.86848,580 shs$2.70 billion11/04/2024$46.76$46.76$47.76$45.37375,841 shs$2.75 billion11/01/2024$45.84$46.76+2.01%$47.01$45.99422,357 shs$2.75 billion10/31/2024$47.62$45.84-3.74%$47.32$45.65439,776 shs$2.69 billion10/30/2024$48.43$47.62-1.67%$48.30$47.44286,069 shs$2.79 billion10/29/2024$48.20$48.43+0.48%$48.62$47.58312,800 shs$2.84 billion10/28/2024$47.26$48.20+1.99%$48.89$47.35356,196 shs$2.84 billion10/25/2024$46.95$47.26+0.66%$47.95$46.83300,209 shs$2.77 billion10/24/2024$46.59$46.95+0.77%$47.21$46.34283,503 shs$2.77 billion10/23/2024$46.44$46.59+0.32%$46.68$45.48415,599 shs$2.74 billion10/22/2024$45.96$46.44+1.04%$46.53$45.33310,093 shs$2.74 billion10/21/2024$46.97$45.96-2.15%$47.03$45.51439,582 shs$2.70 billion10/18/2024$47.02$46.97-0.11%$47.53$46.69588,702 shs$2.77 billion10/17/2024$46.99$47.02+0.06%$47.53$46.68554,537 shs$2.76 billion10/16/2024$47.64$46.99-1.36%$48.02$46.77593,213 shs$2.76 billion Related Companies Amphastar Pharmaceuticals Stock Price Chart Calliditas Therapeutics AB (publ) Stock Price Chart Phibro Animal Health Stock Price Chart Esperion Therapeutics Stock Price Chart Cara Therapeutics Stock Price Chart Catalent Stock Price Chart Qiagen Stock Price Chart Revolution Medicines Stock Price Chart Intra-Cellular Therapies Stock Price Chart Roivant Sciences Stock Price Chart Receive PTGX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Protagonist Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PTGX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protagonist Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protagonist Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
